Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1

Status

Completed 16Unknown 10Active not recruiting 9Terminated 5Recruiting 5Withdrawn 2Not yet recruiting 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 2Thoracic 1Plasma cell 1Myeloid 1Gynecologic 1Classical hematology 1

Conditions

Pancreatic Neoplasms 1Neoplastic Cells, Circulating 1Lynch syndrome I (site-specific colonic cancer) 1

Interventions

Oxaliplatin 86Bevacizumab 66Capecitabine 65Fluorouracil 48tislelizumab 41Gemcitabine 40Drug Therapy 39Leucovorin 38sintilimab 35Irinotecan 34lenvatinib 27Cisplatin 27HMPL-013 25S 1 (combination) 23camrelizumab 22Immune Checkpoint Inhibitors 21irinotecan sucrosofate 20apatinib 20Surgical Procedures, Operative 20Radiotherapy 20Injections 20130-nm albumin-bound paclitaxel 20toripalimab 19Paclitaxel 18Folfox protocol 17pembrolizumab 15Immunotherapy 15Cetuximab 15Specimen Handling 14regorafenib 12

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Not yet recruiting × Aspirin × Gastrointestinal × Clear all
NCT05637567 2023-11-13

ASAP

German Cancer Research Center

Phase 2 Not yet recruiting
170 enrolled
Gastrointestinal

Neoplastic Cells, Circulating, Pancreatic Neoplasms

NCT02497820 2016-08-25

CaPP3 Israel

Tel-Aviv Sourasky Medical Center

Phase 3 Not yet recruiting
1,800 enrolled
Gastrointestinal

Lynch syndrome I (site-specific colonic cancer)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡